In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
After finishing at $2.68 in the prior trading day, Quince Therapeutics Inc (NASDAQ: QNCX) closed at $2.69, up 0.37%. In other words, the price has increased by $0.37 from its previous closing price. On the day, 0.61 million shares were traded. QNCX stock price reached its highest trading level at $2.815 during the session, while it also had its lowest trading level at $2.63.
Ratios:
Our goal is to gain a better understanding of QNCX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.12 and its Current Ratio is at 1.12. In the meantime, Its Debt-to-Equity ratio is 16.97 whereas as Long-Term Debt/Eq ratio is at 0.34.
Upgrades & Downgrades
In the most recent recommendation for this company, Citizens JMP on August 05, 2025, initiated with a Mkt Outperform rating and assigned the stock a target price of $9.
On March 24, 2025, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $10.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 26 ’25 when LUCA BENATTI bought 50,000 shares for $3.46 per share.
Benatti Luca sold 50,000 shares of QNCX for $173,500 on Dec 26 ’25. The Director now owns 39,179 shares after completing the transaction at $3.47 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, QNCX now has a Market Capitalization of 149783200 and an Enterprise Value of 141488208.
Stock Price History:
The Beta on a monthly basis for QNCX is 1.24, which has changed by 0.5549133 over the last 52 weeks, in comparison to a change of 0.19362879 over the same period for the S&P500. Over the past 52 weeks, QNCX has reached a high of $4.55, while it has fallen to a 52-week low of $0.72. The 50-Day Moving Average of the stock is -4.78%, while the 200-Day Moving Average is calculated to be 49.12%.
Shares Statistics:
The stock has traded on average 667.77K shares per day over the past 3-months and 557510 shares per day over the last 10 days, according to various share statistics. A total of 54.49M shares are outstanding, with a floating share count of 48.34M. Insiders hold about 13.18% of the company’s shares, while institutions hold 20.78% stake in the company. Shares short for QNCX as of 1765756800 were 2064545 with a Short Ratio of 3.09, compared to 1763078400 on 1365905. Therefore, it implies a Short% of Shares Outstanding of 2064545 and a Short% of Float of 4.14.
Earnings Estimates
. The current rating of Quince Therapeutics Inc (QNCX) is the result of assessments by 3.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.15 and low estimates of -$0.23.
Analysts are recommending an EPS of between -$1.03 and -$1.15 for the fiscal current year, implying an average EPS of -$1.08. EPS for the following year is -$0.72, with 4.0 analysts recommending between -$0.11 and -$1.24.
